Remove building-a-more-sustainable-future-for-the-pharmaceutical-cold-chain
article thumbnail

Taking Pharmaceutical Cold Chain to the Next Level with Modular Real-Time Monitoring

XTalks

In June 2021, I held a webinar on modular real-time monitoring in the pharmaceutical cold chain together with Berlinger’s Head of Research & Development Bernd Heisterkamp and CEO Thomas Bechter. It confirms that automation and integration are key requirements within the pharmaceutical cold chain.

article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. Water-borne illnesses are also likely to become more common, as increased rain and storm surges contribute to flooding and contaminated run off. In 2019, the pharmaceutical industry produced 48.55

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Molecular Partners Announces Collaboration With Novartis to Develop Two DARPin(R) Therapies Designed for Potential Use Against COVID-19

The Pharma Data

. MP0420 and MP0423 are potential medicines with a unique approach for both the prevention and treatment of COVID-19, with the possibility to manufacture at scale, easy administration and with the potential to bypass cold storage. Novartis is making multiple contributions to the global efforts to combat the COVID-19 pandemic.

article thumbnail

Pfizer and BioNTech to provide 500 million doses of COVID-19 vaccine to U.S. government for donation to poorest nations

The Pharma Data

government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022. Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility. NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S.